期刊文献+

胰腺癌伴随炎症的病理学研究 被引量:1

CLINICOPATHOLOGICAL FEATURES OF INFLAMMATION IN PANCREATIC ADENOCARCINOMA
暂未订购
导出
摘要 目的探讨胰腺癌的炎症病理学特征。方法对76例胰腺腺癌病例的临床资料、HE特点及免疫组化特征进行分析,并复习文献。结果76例胰腺腺癌,有85.53%(65/76)在肿瘤组织中、肿瘤周边及较远胰腺组织中有不同程度的炎细胞浸润,以淋巴细胞、中性粒细胞及组织细胞为主,浆细胞也常常能看到。有93.42%(71/76)肿瘤周边及61.84%(47/76)远处胰腺组织中有不同程度的纤维化。有25.00%(19/76)能看到脂肪坏死。免疫组化显示在肿瘤中浸润的淋巴细胞为T淋巴细胞和B淋巴细胞,而在肿瘤周边以T淋巴细胞为主。结论胰腺癌伴随炎症是一种常见的病理现象,浸润炎细胞以淋巴细胞、中性粒细胞及组织细胞为主,其炎症特征与其生物学行为及术后并发症可能有关。 Obstract To characterize the inflammatory infiltrate in pancreatic adenocarnoma. Methods 76 pancreatic ductal adenocarnoma cases were analyzed by HE and immunohistochemical staining, and the related literature reviewed. Results There were significantly lymphocytes , neutrophilic leukocytes and macrophages in 85.53% (65/76) pancreatic cancers, and plasma ceils were also ofen exist. There were different dense of fibres stroma around the tumor 93.42% (71/76) and in the faror pancreatic tissues 61.84% (47/76) . fat necrosis were seen in 25.00% (19/76) cases. Inmmunostaining revealed T lymphcytes and B lymphcytes infiltrated in- tratumors, and only T lymphcytes infiltrated around the tumor tissues. Conclusions pancreatic adenocarcinoma is characterized by a dense , desmoplastic stroma rich in collagen fibres, fibroblasts, and inflammatory cells. The inflammatory cells inclouds lymphocytes, neutrophilix leukocytes and macrophages. And the inflammatory characteration may influence it's biological behaviour and the complication.
机构地区 解放军总医院
出处 《肝胆外科杂志》 2008年第4期266-269,共4页 Journal of Hepatobiliary Surgery
关键词 胰腺腺癌 炎症 病理学分析 胰腺 pancreatic ductal adenocarcinoma inflammation Clinicopathological features
  • 相关文献

参考文献9

  • 1Solcia E,Capella G, Kloppel G. Tumors of the exocrine pancreas. In:Rosai J,Sobin L,eds. Atlas of tumor pathology. Tumors of the pancreas. Washington DC: Armed Forces Institute of pathology, 1997:64 - 88.
  • 2Esposito I, Menicagli M, Funel N, et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma[ J]. J Clin Pathol, 2004,57:630 - 636.
  • 3Gouon - Evans V, Lin EY, Pollard JW. Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development [ J ]. Breast Cancer Res, 2002,4:155 - 164.
  • 4Wong YC, Wang YZ. Growth factors and epithelial stromal interactions in prostate cancer development [ J ]. Int Rev Cytol, 2000, 199:65 - 116.
  • 5Ribatti D, Vacca A,Nico B, et al. The role of mast cells in tumour angiogenesis[ J]. Br J Haematol,2001,115 :514 -521.
  • 6Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies [ J ]. J Pathol , 2002,196:254 - 265.
  • 7Mroczko B, Szmitkowski M, Czygier M. Granulocyte-colony stimulating factor (G-CSF) in diagnosis and monitoring of non-smallcell lung cancer (NSCLC)[J]. Pol Arch Med Wewn, 2000,103: 163 - 168.
  • 8任学群,李宜雄,陈善正,胡国潢,应娇茜,李劲东,裴海平,陈志康,汤恢焕,吕新生.胰十二指肠切除术后胰瘘的危险因素[J].中国普通外科杂志,2006,15(10):772-776. 被引量:45
  • 9Stemberg,主编,回允中,主译.诊断外科病理学[M].第三版.北京:北京大学医学出版社,2003:1474.

二级参考文献17

  • 1刘威,苗雄鹰,李永国,钟德玝,黄生福,王群伟.静脉输注奥曲肽预防胰十二指肠切除术后胰瘘[J].中国普通外科杂志,2004,13(12):927-929. 被引量:15
  • 2鲁建国,高德明,马庆久,梅乐园,何显力,褚延魁,杜锡林.降低胰十二指肠切除术后胰瘘发生率及病死率的体会[J].中国普通外科杂志,2005,14(11):863-865. 被引量:17
  • 3Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula : an international study group (ISGPF) definition [J].Surgery, 2005, 138(1):8-13.
  • 4Bassi C, Butturini G, Molinari E, et al. Pancreatic fistula rate after pancreatic resection. The importance of definitions [J]. Dig Surg,2004,21(1):54-59.
  • 5Shrikhande SV, Qureshi SS, Rajneesh N , et al. Pancreatic anastomoses after pancreaticoduodenectomy: do we need further studies ?[J], World J Surg,2005, 29(12):1642-1649.
  • 6Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy ? Results of a prospective randomized placebo-controlled trial [J]. Ann Surg, 2000, 232(3): 419-429.
  • 7Lin JW, Cameron JL, Yeo CJ, et al. Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula [J]. J Gastrointest Surg, 2004, 8(8): 951-959.
  • 8Bassi C, Falconi M, Molinari E, et al. Duct-to-mucosa versus end-to-side pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: results of a prospective randomized trial [J].Surgery, 2003, 134(5):766-771.
  • 9Bassi C, Falconi M, Molinari E, et al. Reconstruction by pancreaticojejunostomy versus pancreaticogastrustomy following pancreatectomy : results of a comparative study [J]. Ann Surg, 2005,242(6):767-773.
  • 10Popiela T, Kedra B, Sierzega M, et al. Risk factors of pancreatic fistula following pancreaticoduodenectomy for periampullary cancer[J]. Hepatogastroenterology, 2004, 51(59): 1484-1488.

共引文献44

同被引文献8

  • 1Lee K S, Lee H J, Ahn K S, et al. Cyclooxygenase-2/prostaglan- din E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells [ J ]. Cancer Lett, 2009, 280 ( 1 ) : 93.
  • 2Kang Y j, Chung H J, Nam J W, et al. Cytotoxic and antineo- plastic activity of timosaponin A-Ill for human colon cancer cells [J]. JNat Prod, 2011, 74(4):701.
  • 3King F W, Fong S, Griffin C, et al. Timosaponin AIll is preferen- tially cytotoxic to tumor cells through inhibition of mTOR and in- duction of ER stress [ J]. PLoS One, 2009, 4(9) : e7283.
  • 4Sy L K, Yah S C, Lok C N, et aL Timosaponin A-Ill induees au- tophagy preceding mitochondria-mediated apoptosis in Hel,a cancer cells [J]. Cancer Res, 2008, 68(24) : 10229.
  • 5Fujioka S, Yoshida K, Yanagisawa S, et al. Angiogenesis in pan- creatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predic- tors of overall and relapse-free survival [ J] Cancer, 2001, 92 (7) : 1788.
  • 6Wey J S, Fan F, Gray M J. Vascular endothelial growth factor re- ceptor-1 promotes migration and invasion in pancreatic carcinoma cell lines [J]. Cancer, 2005, 104(2): 427.
  • 7翟笑枫.红景天抗肿瘤作用机制研究进展[J].中国民族民间医药,2010,19(17):3-4. 被引量:8
  • 8李琴,商晶.甲基莲心碱的药理作用研究进展[J].海峡药学,2012,24(1):37-39. 被引量:16

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部